Down-regulation of interleukin-10 expression and production is associated with spontaneous proliferation by lymphocytes from human T lymphotropic virus type II-Infected persons

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1489-1496

  Dezzutti, Charlene S ^a   Sasso, Donna R ^a   Rudolph, Donna L ^a   Lal, Renu B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE; VIRUS CELL INTERACTION;

EID: 0031780476     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515311     Document Type: Article

References (14)

1. Prince HE, Kleinman S, Doyle M, Lee H, Swanson P. Spontaneous lymphocyte proliferation in vitro characterizes both HTLV-I and HTLV-II infection. J Acquir Immune Defic Syndr 1990;3:1199-200.
2. Yasuda K, Sei Y, Yokoyama MM, Tanaka K, Hara A. Healthy HTLV-I carriers in Japan: the haematological and immunological characteristics. Dr J Haematol 1986;64:195-203.
3. Prince HE, Weber DM, Jensen ER. Spontaneous lymphocyte proliferation in HTLV-I/II infection reflects preferential activation of CD8 and CD16/56 cell subsets. Clin Immunol Immunopathol 1991;58:419-30.
4. Rosenblatt JD, Plaeger-Marshall S, Giorgi JV, et al. A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users. Blood 1990;76:409-17.
5. Dezzutti CS, Rudolph DL, Lal RB. Infection with human T-lymphotropic virus types I and II results in alterations of cellular receptors, including the up-modulation of T-cell counter receptors CD40, CD54, and CD80 (B7-1). Clin Diagn Lab Immunol 1995;2:349-55,
6. Dezzutti CS, Rudolph DL, Dhawan S, Lal RB. Modulation of HTLV-II-associated spontaneous lymphocyte proliferation by β2 integrin CD11a/CD18 involves interaction with its cognate ligand, CD54. Cell Immunol 1994;156:113-23.
7. Kimata JT, Palker TJ, Ratner L. The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway. J Virol 1993;67:3134-41.
8. Lal RB, Rudolph DL, Dezzutti CS, Linsley PS, Prince HD. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands. J Immunol 1996;157:1288-96.
9. Wucherpfennig KW, Höllsberg P, Richardson JH, Benjamin D, Hafler DA. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc Natl Acad Sci USA 1992;89:2110-4.
10. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995;103:161-79.
11. Liles WC, Van Voorhis WC. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis 1995;172:1573-80.
12. Tendler CL, Greenberg SJ, Blattner WA, et al. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci USA 1990;87:5218-22.
13. Lal RB, Rudolph DL. Constitutive production of interleukin-6 and tumor necrosis factor-α from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type-I/II. Blood 1990;78:571-4.
14. Lal RB, Hjelle B, Rudolph DL. Spontaneous proliferation of HTLV-II-infected peripheral blood lymphocytes: HLA-DR-driven, IL-2-dependent response. Microbiol Immunol 1992;36:865-72.